ClinicalTrials.govpublic full text
Investigate the Efficacy and Safety of GSK1070806 in Obese Subjects With T2DM
diabetes mellitus, efficacy, obese, t2dm, il-18, monoclonal antibody (mab), interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 843977
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.